Intended for healthcare professionals


In brief

BMJ 1997; 315 doi: (Published 20 September 1997) Cite this as: BMJ 1997;315:697

Slimming drugs withdrawn following heart scare: The drugs dexfenfluramine and fenfluramine have been withdrawn worldwide by their manufacturers following reports of heart valve defects in the United States. No similar cases have been reported in the UK.

Move of blood testing from Liverpool to Manchester to go ahead: Professor John Cash, asked to head an independent review …

View Full Text

Log in

Log in through your institution


* For online subscription